Matches in SemOpenAlex for { <https://semopenalex.org/work/W2782421307> ?p ?o ?g. }
- W2782421307 endingPage "303" @default.
- W2782421307 startingPage "288" @default.
- W2782421307 abstract "Abstract Blood-based biomarkers are critical in metastatic prostate cancer, where characteristic bone metastases are not readily sampled, and they may enable risk stratification in localized disease. We established a sensitive and high-throughput strategy for analyzing prostate circulating tumor cells (CTC) using microfluidic cell enrichment followed by digital quantitation of prostate-derived transcripts. In a prospective study of 27 patients with metastatic castration-resistant prostate cancer treated with first-line abiraterone, pretreatment elevation of the digital CTCM score identifies a high-risk population with poor overall survival (HR = 6.0; P = 0.01) and short radiographic progression-free survival (HR = 3.2; P = 0.046). Expression of HOXB13 in CTCs identifies 6 of 6 patients with ≤12-month survival, with a subset also expressing the ARV7 splice variant. In a second cohort of 34 men with localized prostate cancer, an elevated preoperative CTCL score predicts microscopic dissemination to seminal vesicles and/or lymph nodes (P < 0.001). Thus, digital quantitation of CTC-specific transcripts enables noninvasive monitoring that may guide treatment selection in both metastatic and localized prostate cancer. Significance: There is an unmet need for biomarkers to guide prostate cancer therapies, for curative treatment of localized cancer and for application of molecularly targeted agents in metastatic disease. Digital quantitation of prostate CTC-derived transcripts in blood specimens is predictive of abiraterone response in metastatic cancer and of early dissemination in localized cancer. Cancer Discov; 8(3); 288–303. ©2018 AACR. See related commentary by Heitzer and Speicher, p. 269. This article is highlighted in the In This Issue feature, p. 253" @default.
- W2782421307 created "2018-01-12" @default.
- W2782421307 creator A5005029294 @default.
- W2782421307 creator A5005314279 @default.
- W2782421307 creator A5009816218 @default.
- W2782421307 creator A5010182874 @default.
- W2782421307 creator A5010827977 @default.
- W2782421307 creator A5010837144 @default.
- W2782421307 creator A5012006013 @default.
- W2782421307 creator A5012704679 @default.
- W2782421307 creator A5017713308 @default.
- W2782421307 creator A5017925159 @default.
- W2782421307 creator A5025565506 @default.
- W2782421307 creator A5026510674 @default.
- W2782421307 creator A5027636442 @default.
- W2782421307 creator A5033076595 @default.
- W2782421307 creator A5035481632 @default.
- W2782421307 creator A5038280749 @default.
- W2782421307 creator A5039517650 @default.
- W2782421307 creator A5041851129 @default.
- W2782421307 creator A5045204506 @default.
- W2782421307 creator A5045740849 @default.
- W2782421307 creator A5048513152 @default.
- W2782421307 creator A5065576841 @default.
- W2782421307 creator A5069961391 @default.
- W2782421307 creator A5071788399 @default.
- W2782421307 creator A5072031212 @default.
- W2782421307 creator A5074342920 @default.
- W2782421307 creator A5075867487 @default.
- W2782421307 date "2018-03-01" @default.
- W2782421307 modified "2023-10-01" @default.
- W2782421307 title "An RNA-Based Digital Circulating Tumor Cell Signature Is Predictive of Drug Response and Early Dissemination in Prostate Cancer" @default.
- W2782421307 cites W1480376833 @default.
- W2782421307 cites W1701091641 @default.
- W2782421307 cites W1827081793 @default.
- W2782421307 cites W1951061860 @default.
- W2782421307 cites W1964307267 @default.
- W2782421307 cites W1974950800 @default.
- W2782421307 cites W1980732835 @default.
- W2782421307 cites W1994395871 @default.
- W2782421307 cites W2037578297 @default.
- W2782421307 cites W2042194227 @default.
- W2782421307 cites W2059487933 @default.
- W2782421307 cites W2066588899 @default.
- W2782421307 cites W2076149015 @default.
- W2782421307 cites W2080748037 @default.
- W2782421307 cites W2103444700 @default.
- W2782421307 cites W2110735634 @default.
- W2782421307 cites W2117098158 @default.
- W2782421307 cites W2117460748 @default.
- W2782421307 cites W2117792530 @default.
- W2782421307 cites W2119494825 @default.
- W2782421307 cites W2129128353 @default.
- W2782421307 cites W2137467802 @default.
- W2782421307 cites W2148998801 @default.
- W2782421307 cites W2150865892 @default.
- W2782421307 cites W2152561234 @default.
- W2782421307 cites W2156923287 @default.
- W2782421307 cites W2158176392 @default.
- W2782421307 cites W2161112598 @default.
- W2782421307 cites W2178232667 @default.
- W2782421307 cites W2181283187 @default.
- W2782421307 cites W2197766619 @default.
- W2782421307 cites W2235405584 @default.
- W2782421307 cites W2238189315 @default.
- W2782421307 cites W2262087934 @default.
- W2782421307 cites W2278392405 @default.
- W2782421307 cites W2419426348 @default.
- W2782421307 cites W2505088672 @default.
- W2782421307 cites W2506217192 @default.
- W2782421307 cites W2523396458 @default.
- W2782421307 cites W2572403213 @default.
- W2782421307 cites W2604800509 @default.
- W2782421307 cites W2620746860 @default.
- W2782421307 doi "https://doi.org/10.1158/2159-8290.cd-16-1406" @default.
- W2782421307 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6342192" @default.
- W2782421307 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29301747" @default.
- W2782421307 hasPublicationYear "2018" @default.
- W2782421307 type Work @default.
- W2782421307 sameAs 2782421307 @default.
- W2782421307 citedByCount "100" @default.
- W2782421307 countsByYear W27824213072018 @default.
- W2782421307 countsByYear W27824213072019 @default.
- W2782421307 countsByYear W27824213072020 @default.
- W2782421307 countsByYear W27824213072021 @default.
- W2782421307 countsByYear W27824213072022 @default.
- W2782421307 countsByYear W27824213072023 @default.
- W2782421307 crossrefType "journal-article" @default.
- W2782421307 hasAuthorship W2782421307A5005029294 @default.
- W2782421307 hasAuthorship W2782421307A5005314279 @default.
- W2782421307 hasAuthorship W2782421307A5009816218 @default.
- W2782421307 hasAuthorship W2782421307A5010182874 @default.
- W2782421307 hasAuthorship W2782421307A5010827977 @default.
- W2782421307 hasAuthorship W2782421307A5010837144 @default.
- W2782421307 hasAuthorship W2782421307A5012006013 @default.
- W2782421307 hasAuthorship W2782421307A5012704679 @default.
- W2782421307 hasAuthorship W2782421307A5017713308 @default.
- W2782421307 hasAuthorship W2782421307A5017925159 @default.